Meaningful Contributions

'biotechnology' Archive

Susan Band Horwitz ’58 Receives 2014 John Scott Award

Posted November 21, 2014
susan_band_horwitz_web

Susan Band Horwitz ’58, an internationally renowned molecular pharmacologist whose research on the drug Taxol led to its becoming one of the world’s most successful drugs in the fight against cancer, is one of three scientists to receive the 2014 John Scott Award, one of the top prizes in the world of science and medicine. Presented by […]

Mercedes K. Meyer ’88 Inducted as Secretary of AIPLA

Posted November 15, 2012

Mercedes K. Meyer ’88 was inducted as secretary of the American Intellectual Property Law Association (AIPLA) on Oct. 27 and will serve a one-year post. Meyer is a partner in Drinker Biddle’s Intellectual Property practice group. Meyer focuses her extensive practice on biotechnology and pharmaceutical patent prosecution. Immediately prior to her appointment as AIPLA secretary, […]

Barbara Fox ’78 Named to Mass High Tech’s 2012 “Women to Watch” List

Posted May 2, 2012
photo of Barbara Fox

The business journal Mass High Tech has named Barbara Fox ’78, the  founder, leader and chief science officer of Avaxia Biologics, to its 2012 list of “Women to Watch.” Fox, who majored in chemistry at Bryn Mawr before going on to earn a Ph.D. at the Massachusetts Institute of Technology, holds a number of patents. “With three […]

George Morrow, M.A. ’77, Appointed to Human Genome Sciences Board of Directors

Posted April 21, 2011

Human Genome Sciences, Inc., a biopharmaceutical corporation that uses the human DNA sequence to develop protein and antibody drugs, announced in March that George Morrow, M.A. ’77, had been appointed to the HGS Board of Directors. Until January 2011, Morrow served as executive vice president for global commercial operations for Amgen, Inc., leading all of […]

With Susan Kelly Barnes ’76 at the Financial Helm, Pacific Biosciences Raises $200 Million in IPO

Posted October 29, 2010
photo of Susan Kelly Barnes

Pacific Biosciences of California, whose chief financial officer is Susan Kelly Barnes ’76, makes superfast DNA sequencing machines with the potential to transform biological research. The company offered shares for sale to members of the public for the first time on Oct. 27, successfully raising its initial public offering (IPO) goal of $200 million. Based […]